These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 476283)

  • 61. Steady-state kinetics of imipramine in transgenic mice with elevated serum AAG levels.
    Holladay JW; Dewey MJ; Yoo SD
    Pharm Res; 1996 Sep; 13(9):1313-6. PubMed ID: 8893267
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of the EMIT amitriptyline and nortriptyline assays for the determination of serum clomipramine and desmethylclomipramine.
    Fraser AD; Bryan W; Isner AF
    Ther Drug Monit; 1989; 11(3):349-53. PubMed ID: 2658213
    [TBL] [Abstract][Full Text] [Related]  

  • 63. GLC method for iminodibenzyl and desipramine impurities in imipramine hydrochloride and its formulated products.
    Thompson DW
    J Pharm Sci; 1982 May; 71(5):536-8. PubMed ID: 7097500
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms.
    Nagy A; Treiber L
    J Pharm Pharmacol; 1973 Aug; 25(8):599-603. PubMed ID: 4148426
    [No Abstract]   [Full Text] [Related]  

  • 65. The pharmacokinetics of clomipramine and desmethylclomipramine in dogs: parameter estimates following a single oral dose and 28 consecutive daily oral doses of clomipramine.
    Hewson CJ; Conlon PD; Luescher UA; Ball RO
    J Vet Pharmacol Ther; 1998 Jun; 21(3):214-22. PubMed ID: 9673963
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.
    Sindrup SH; Gram LF; Skjold T; Grodum E; Brøsen K; Beck-Nielsen H
    Br J Clin Pharmacol; 1990 Nov; 30(5):683-91. PubMed ID: 2271367
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Imipramine metabolites in blood of patients during therapy and after overdose.
    Gram LF; Bjerre M; Kragh-Sørensen P; Kvinesdal B; Molin J; Pedersen OL; Reisby N
    Clin Pharmacol Ther; 1983 Mar; 33(3):335-42. PubMed ID: 6825388
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of plasma and serum levels of two tricyclic antidepressants: imipramine and desipramine.
    Saady JJ; Bloom VL; Narasimhachari N; Goldberg SC; Friedel RO
    Psychopharmacology (Berl); 1981; 75(2):173-4. PubMed ID: 6798606
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantification of imipramine and desipramine in plasma by high-performance liquid chromatography and fluorescence detection.
    Reece PA; Zacest R; Barrow CG
    J Chromatogr; 1979 Jul; 163(3):310-4. PubMed ID: 541386
    [No Abstract]   [Full Text] [Related]  

  • 70. Decreased plasma concentrations of imipramine and desipramine following cholestyramine intake in depressed patients.
    Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
    Ther Drug Monit; 1994 Aug; 16(4):432-4. PubMed ID: 7974637
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics.
    Brøsen K; Gram LF; Klysner R; Bech P
    Eur J Clin Pharmacol; 1986; 30(1):43-9. PubMed ID: 3709631
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine.
    Weigmann H; Härtter S; Bagli M; Hiemke C
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):401-5. PubMed ID: 10974613
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacokinetics of clomipramine in dogs following single-dose and repeated-dose oral administration.
    King JN; Maurer MP; Altmann BO; Strehlau GA
    Am J Vet Res; 2000 Jan; 61(1):80-5. PubMed ID: 10630784
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A; Johansson R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):145-60. PubMed ID: 1102994
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Improved clean-up procedure for the high-performance liquid chromatographic assay of clomipramine and its demethylated metabolite in human plasma.
    Altieri I; Pichini S; Pacifici R; Zuccaro P
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):416-7. PubMed ID: 7581922
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quantification of imipramine and its major metabolites in whole blood, brain, and other tissues of the rat by liquid chromatography.
    Stout SA; DeVane CL
    Psychopharmacology (Berl); 1984; 84(1):39-41. PubMed ID: 6436888
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relevance of tryptophan and tyrosine availability in endogenous and 'non-endogenous' depressives treated with imipramine or clomipramine.
    Møller SE; Reisby N; Ortmann J; Elley J; Krautwald O
    J Affect Disord; 1981 Sep; 3(3):231-44. PubMed ID: 6456290
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative clinical evaluation of lofepramine and imipramine. Pharmacological aspects.
    Siwers B; Borg S; d'Elia G; Lundin G; Forshell GP; Raotma H; Román G
    Acta Psychiatr Scand; 1977 Jan; 55(1):21-31. PubMed ID: 320828
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Determination of tricyclic antidepressant, clomipramine (Anafranil), in plasma by a specific radioimmunoassay procedure.
    Read GF; Riad-Fahmy D
    Clin Chem; 1978 Jan; 24(1):36-40. PubMed ID: 563311
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A fatal overdose with clomipramine.
    Meatherall RC; Guay DR; Chalmers JL; Keenan JR
    J Anal Toxicol; 1983; 7(4):168-71. PubMed ID: 6632798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.